Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: The effect of dendrimer generation and charge ratio

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 359-369

  Nomani, Alireza ^a,d   Haririan, Ismaeil ^a,c   Rahimnia, Ramin ^a,b   Fouladdel, Shamileh ^a   Gazori, Tarane ^a   Dinarvand, Rassoul ^a   Omidi, Yadollah ^a   Azizi, Ebrahim ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Biomaterials Research Center (BRC)   (Iran)

^d ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antisense oligonucleotide; Cell uptake; Cytotoxicity; Epidermal growth factor receptor; PAMAM; Poly(amido amine) dendrimer

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DENDRIMER; DOUBLE STRANDED DNA; NANOPARTICLE; POLYAMIDOAMINE; POLYETHYLENEIMINE; COMPLEMENTARY DNA; PAMAM STARBURST;

ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STABILITY; HUMAN; HUMAN CELL; MOLECULAR SIZE; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SURFACE CHARGE; ZETA POTENTIAL; BREAST TUMOR; CHEMISTRY; CONFORMATION; CRYSTALLIZATION; DIFFUSION; MACROMOLECULE; MATERIALS TESTING; METHODOLOGY; SURFACE PROPERTY; TUMOR CELL LINE; ULTRASTRUCTURE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CRYSTALLIZATION; DENDRIMERS; DIFFUSION; DNA, ANTISENSE; HUMANS; MACROMOLECULAR SUBSTANCES; MATERIALS TESTING; MOLECULAR CONFORMATION; NANOPARTICLES; SURFACE PROPERTIES;

EID: 77956633555     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Guinn BA, Mulherkar R. International progress in cancer gene therapy. Cancer Gene Ther. 2008;15(12):765-775.
2. Strayer DS, Akkina R, Bunnell BA, et al. Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther. 2005;11(6):823-842.
3. Atkinson TJ. Cystic fibrosis, vector-mediated gene therapy, and relevance of toll-like receptors: A review of problems, progress, and possibilities. Curr Gene Ther. 2008;8(3):201-207.
4. Youjin S, Jun Y. The treatment of hemophilia A: From protein replacement to AAV-mediated gene therapy. Biotechnol Lett. 2009;31(3):321-328.
5. Rolland A. Gene medicines: The end of the beginning? Adv Drug Deliv Rev. 2005;57(5):669-673.
6. Kataoka K, Harashima H. Gene delivery systems: viral vs non-viral vectors. Adv Drug Deliv Rev. 2001;52(3):151.
7. Itaka K, Kataoka K. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur J Pharm Biopharm. 2009;71(3):475-483.
8. The Journal of Gene Medicine Clinical Trial site, Available from: http://www.wiley.co.uk/genmed/clinical/, Accessed February 2010.
9. Dufes C, Uchegbu IF, Schtzlein AG. Dendrimers in gene delivery. Adv Drug Deliv Rev. 2005;57(15):2177-2202.
10. Lee CC, MacKay JA, chet JMJ, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol. 2005;23(12):1517-1526.
11. Tomalia DA, Baker H, Dewald J, et al. New class of polymers:Starburst dendritic macromolecules. Polym J. 1984;17(1):117-132.
12. Svenson S, Tomalia DA. Dendrimers in biomedical applications: reflections on the field. Adv Drug Deliv Rev. 2005;57(15):2106-2129.
13. Cheng Y, Wang J, Rao T, He X, Xu T. Pharmaceutical applications of dendrimers: Promising nanocarriers for drug delivery. Front Biosci. 2008;13(4):1447-1471.
14. Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans. 2007;35(1):61-67.
15. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6(8):427-436.
16. Haensler J, Szoka FC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem. 1993; 4(5):372-379.
17. Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem. 1996;7(6):703-714.
18. Eichman JD, Bielinska AU, Kukowska-Latallo JF, Baker J. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm Sci Technol Today. 2000;3(7):232-245.
19. Bielinska A, Kukowska-Latallo JF, Johnson J, Tomalia DA, Baker J. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 1996;24(11):2176-2182.
20. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev. 2005;57(15):2215-2237.
21. Malik N, Wiwattanapatapee R, Klopsch R, et al. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release. 2000;65(1-2):133-148.
22. Hollins AJ, Omidi Y, Benter IF, Akhtar S. Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity. J Drug Target. 2007;15(1):83-88.
23. Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF. The lowergeneration polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res. 2002;19(7):960-967.
24. Hollins AJ, Benboubetra M, Omidi Y, et al. Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor. Pharm Res. 2004;21(3):458-466.
25. Arteaga CL. Epidermal growth factor receptor dependence in human tumors: More than just expression? Oncologist. 2002;7(Suppl 4):31-39.
26. Juliano RL. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes. Ann NY Acad Sci. 2006;1082:18-26.
27. ISIS Co. official web page, Available from: http://www.isispharm.com/Pipeline/index.htm, Accessed February 2010.
28. Petch AK, Sohail M, Hughes MD, et al. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides. Biochem Pharmacol. 2003;66(5):819-830.
29. Tomalia DA, Baker H, Dewald J, et al. Dendritic macromolecules: synthesis of starburst dendrimers. Macromolecules. 1986;19(9): 2466-2468.
30. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl Acad Sci U S A. 1995;92(16):7297-7301.
31. Bloomfield VA. DNA condensation by multivalent cations. Biopolymers. 1997;44(3):269-282.
32. Hud NV, Vilfan ID. Toroidal DNA condensates: Unraveling the fine structure and the role of nucleation in determining size. Annu Rev Biophys Biomolec Struct. 2005;34(1):295-318.
33. Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 1997;4(8):823-832.
34. Kabanov VA, Sergeyev VG, Pyshkina OA, et al. Interpolyelectrolyte complexes formed by DNA and astramol poly(propylene imine) dendrimers. Macromolecules. 2000;33(26):9587-9593.
35. Fant K, Esbjorner EK, Lincoln P, Norden B. DNA condensation by PAMAM dendrimers: Self-assembly characteristics and effect on transcription. Biochemistry. 2008;47(6):1732-1740.
36. Su CJ, Chen HL, Wei MC, Peng SF, Sung HW, Ivanov VA. Columnar mesophases of the complexes of DNA with low-generation poly(amido amine) dendrimers. Biomacromolecules. 2009;10:773-783.
37. Carnerup AM, Ainalem ML, Alfredsson V, Nylander T. Watching DNA condensation induced by poly(amido amine) dendrimer with timeresolved cryo-TEM. Langmuir. 2009;25(21):12466-12470.
38. Kunze KK, Netz RR. Salt-induced DNA-histone complexation. Phys Rev Lett. 2009;20(85):4389-4392.
39. Navarro G, Tros de Ilarduya C. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomed Nanotechnol Biol Med. 2009;5(3):287-297.
40. Yoo H, Sazani P, Juliano RL. PAMAM dendrimers as delivery agents for antisense oligonucleotides. Pharm Res. 1999;16(12): 1799-1804.
41. Peetla C, Labhasetwar V. Effect of molecular structure of cationic surfactant on biophysical interaction of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir. 2009;25: 2369-2377.
42. Chen J, Hessler JA, Putchakayala K, et al. Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. J Phys Chem B. 2009;113(32):11179-11185.
43. Ginzburg VV, Balijepalli S. Modeling the thermodynamics of the interaction of nanoparticles with cell membranes. Nano Lett. 2007;7(12):3716-3722.
44. Lee H, Larson RG. Molecular dynamics simulations of PAMAM dendrimer- induced pore formation in DPPC bilayers with a coarse-grained model. J Phys Chem B. 2006;110(37):18204-18211.
45. Lee H, Larson RG. Coarse-grained molecular dynamics studies of the concentration and size dependence of fifth- and seventh-generation PAMAM dendrimers on pore formation in DMPC bilayer. J Phys Chem B. 2008;112(26):7778-7784.
46. Parimi S, Barnes TJ, Prestidge CA. PAMAM dendrimer interactions with supported lipid bilayers: a kinetic and mechanistic investigation. Langmuir. 2008;24(23):13532-13539.
47. Leroueil PR, Berry SA, Duthie K, et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett. 2008;8(2):420-424.
48. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006;114(1): 100-109.
49. Nomani A, Fouladdel S, Haririan I, et al. The impact of poly (amido amine) dendrimer-oligonucleotide nanoparticles on T47D cells in culture. Proceeding of 36th Annual Meeting of Controlled Release Society; 2009 Jul 18-22; Copenhagen, Denmark, CRS society publication; 2009. p. 81.